Jia et al [31] reported that the sensitivity of drug-resistant ovarian cancer cells to platinum was improved by blocking the PI3K/Akt pathway with lysophosphatidic acid receptor gene KD. This evidence concerns the gene AKT1 and ovarian carcinoma.